Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

EpilepsyMigraine and Headache
Do you want to read an article? Please log in or register.